Ed Pershing is listed as a director on 2 SEC Form D filings by 1 issuer between Aug 2021 and Oct 2022: PROVECTUS BIOPHARMACEUTICALS, INC. (Knoxville, TN — pharmaceuticals — 2021–2022; $7.94M reported sold to 90 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for Ed Pershing and found 4 differences: Form D filed 35 days after the first sale; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.